Latest return on equity
Context Therapeutics Return on equity
Direct answer
Context Therapeutics's return on equity is -76.14%.
The verified market snapshot reports -76.14%.
Bullstory displays the reported value and does not estimate missing data.
Market data checked October 11, 2026.
Get free Context Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Return on equity
- -76.14%
Explore related company data
View Context Therapeutics's market capitalizationView Context Therapeutics's price-to-book ratioView Context Therapeutics's dividend yieldView Context Therapeutics's 52-week price rangeView Context Therapeutics's profit marginView Context Therapeutics's debt-to-equity ratioView all Context Therapeutics key metricsReturn to Context Therapeutics profile